| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.15▼ | 1.15▼ | 1.15▼ | 1.16▼ | 1.27▼ |
| MA10 | 1.15▼ | 1.16▼ | 1.15▼ | 1.22▼ | 1.41▼ |
| MA20 | 1.15▼ | 1.16▼ | 1.15▼ | 1.29▼ | 1.33▼ |
| MA50 | 1.15▼ | 1.17▼ | 1.21▼ | 1.45▼ | 1.27▼ |
| MA100 | 1.16▼ | 1.24▼ | 1.28▼ | 1.31▼ | 1.35▼ |
| MA200 | 1.23▼ | 1.39▼ | 1.44▼ | 1.26▼ | 49,298.82▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.001▼ | 0.003▲ | -0.014▼ | 0.341▲ |
| RSI | 44.756▼ | 44.538▼ | 42.498▼ | 35.334▼ | 29.126▼ |
| STOCH | 33.889 | 30.258 | 50.298 | 28.648 | 20.677 |
| WILL %R | -100.000▼ | -87.500▼ | -87.500▼ | -73.973 | -88.191▼ |
| CCI | -117.544▼ | -94.553 | -113.131▼ | -95.160 | -127.855▼ |
|
Tuesday, July 07, 2026 05:22 AM
Allarity Therapeutics is now poised to run its DRP® testing in-house in a CLIA-certified laboratory environmentThe FDA requires that ...
|
|
Tuesday, June 30, 2026 05:26 AM
Key U.S. patent now protects exclusivity for developing stenoparib with the stenoparib-DRP® until April 2042 TARPON SPRINGS, Fla., June 30, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the ...
|
|
Monday, June 15, 2026 08:55 AM
Track conference calls, annual meetings, summits, analyst days and other corporate events scheduled for Allarity Therapeutics Inc. Use the full market events calendar to scan activity across all ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/07/26 | 1.13 | 1.17 | 1.13 | 1.13 | 53,638 |
| 10/07/26 | 1.19 | 1.21 | 1.1101 | 1.165 | 97,037 |
| 09/07/26 | 1.14 | 1.20 | 1.14 | 1.20 | 50,800 |
| 08/07/26 | 1.13 | 1.185 | 1.065 | 1.16 | 161,606 |
| 07/07/26 | 1.19 | 1.19 | 1.035 | 1.13 | 429,997 |
| 06/07/26 | 1.2962 | 1.31 | 1.19 | 1.20 | 150,106 |
| 02/07/26 | 1.30 | 1.40 | 1.28 | 1.31 | 116,466 |
| 01/07/26 | 1.28 | 1.34 | 1.28 | 1.33 | 121,808 |
| 30/06/26 | 1.28 | 1.3347 | 1.26 | 1.29 | 166,698 |
| 29/06/26 | 1.30 | 1.3437 | 1.26 | 1.30 | 70,521 |
|
|
||||
|
|
||||
|
|